STAT+: Biogen lupus drug improves skin clearance in mid-stage study

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Insilico Medicine signed a large deal with Eli Lilly over AI-driven drug discovery, and there’s a psoriasis race underway.

Let’s get to it.

Continue to STAT+ to read the full story…